Glenn D. Yeik resigned from the offices of Chairman, CEO, President and director of the Board of Directors of the Trimedyne, Inc.(OTCMKTS:TMED). This resignation was not a result of any disagreement with the Company, its management or the Company’s Board or any matter relating to the Company’s operations, policies or practices.

In addition, on September 21, 2016, Jeffrey S. Rudner resigned from the implied position of Principal Financial Officer as certifier of the Company’s future financial statements filed with the Securities Exchange Commission. This resignation was not a result of any disagreement with the Company, its management or the Company’s Board or any matter relating to the Company’s operations, policies or practices.

Further, Marvin P. Loeb, current Scientific Officer and a director, was elected to the additional offices of Chairman of the Board of Directors, CEO and President of the Company effective September 28, 2016.